UTMD Key Stats
- UTAH MEDICAL PRODUCTS INC Files SEC form 10-Q, Quarterly Report May 8
- Utah Medical Products, Inc. (UTMD) Declares $0.245 Quarterly Dividend; 2.1% Yiel... May 7
- Utah Medical Products, Inc. Announces Quarterly Dividend GlobeNewswire May 7
- UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Submission of Matters to a Vote of... May 7
- Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2013 noodls Apr 25
- Utah Medical Products (UTMD) Reports Q1 EPS of $0.73 Street Insider Apr 25
- UTAH MEDICAL PRODUCTS INC Files SEC form 8-K, Results of Operations and Financia... Apr 25
- Utah Medical Products About To Put More Money In Your Pocket Mar 13
- UTAH MEDICAL PRODUCTS INC Files SEC form 10-K, Annual Report Mar 7
- Will Utah Medical Keep Performing In 2013? Mar 4
UTMD Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Utah Medical Products is up 50.58% over the last year vs S&P 500 Total Return up 28.33%, Rochester Medical Corporation up 44.77%, and Baeta down 36.67%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for UTMD
Pro Report PDF for UTMD
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download UTMD Pro Report PDF
Pro Strategies Featuring UTMD
Did Utah Medical Products make it into our Pro Portfolio Strategies?